Business Wire

Pear Therapeutics and Serve You Rx Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® and People with Substance and Opioid Use Disorders

Serve You Rx teams with Pear to lead access to prescription digital therapeutics (PDTs) with proven outcomes in treating substance use disorder (SUD) and opioid use disorder (OUD) and to support ...
Nasdaq

Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today ...
MobiHealthNews

Pear's reSET-O DTx lowers costs, enhances quality of life in new study

Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years compared with normal treatment alone. Treatment as usual was ...
Nasdaq

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List

BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced ...
Business Wire

Oklahoma Health Care Authority and Pear Therapeutics Enter into Value-Based Agreement for reSET® and reSET-O®

BOSTON & OKLAHOMA CITY--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR), the parent company of Pear Therapeutics (US), Inc., the leader in developing and commercializing software-based ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...
MobiHealthNews

MassHealth to cover Pear Therapeutics' reSET and reSET-O

Pear Therapeutics announced Wednesday that Massachusetts’ Medicaid program plans to cover its digital prescription therapeutics for treating substance and opioid use disorders, reSET and reSET-O. The ...
FierceBiotech

Pear's digital therapeutic for alcohol use disorder bears fruit with FDA breakthrough tag

With its proposed special purpose acquisition company deal only days away from shareholder approval, Pear Therapeutics is already plotting out its future as a publicly traded company. After ...
Benzinga.com

Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP

Alcohol is the most common substance use disorder (SUD), representing 70% of the more than 40 million people with SUD 1 Pear Therapeutics, Inc. PEAR, the leader in developing and commercializing ...
STAT

Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system. In recent ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...